Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Mapping of antigenic sites on the nucleocapsid protein of the severe acute respiratory syndrome coronavirus

Identifieur interne : 000235 ( PascalFrancis/Curation ); précédent : 000234; suivant : 000236

Mapping of antigenic sites on the nucleocapsid protein of the severe acute respiratory syndrome coronavirus

Auteurs : YUXIAN HE [États-Unis] ; YUSEN ZHOU [République populaire de Chine] ; HAO WU [République populaire de Chine] ; ZHIHUA KOU [République populaire de Chine] ; SHUWEN LIU [États-Unis] ; SHIBO JIANG [États-Unis]

Source :

RBID : Pascal:05-0019887

Descripteurs français

English descriptors

Abstract

Antigenic sites on the nucleocapsid (N) protein of severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) were mapped by Pepscan analysis with overlapping peptides that span the N protein sequence. Two major immunodominant epitopes located in the C-terminal region (amino acids [aal 362 to 412) and middle region (aa 153 to 178) reacted with more than 75% of sera from SARS patients. Several minor immunodominant epitopes were reactive with about 50% of the SARS sera. Antisera from mice immunized with inactivated SARS-CoV recognized the two major immunodominant epitopes and one antigenic site located adjacent to the N-terminal region (aa 76 to 101), which did not react with the sera from SARS patients. Several monoclonal antibodies against SARS-CoV bound to the N- or C-terminal antigenic sites. These results suggest that the above antigenic sites on the N protein are important in eliciting humoral immune response against SARS-CoV in humans and animals and can be used as antigens for developing diagnostic tests.
pA  
A01 01  1    @0 0095-1137
A02 01      @0 JCMIDW
A03   1    @0 J. clin. microbiol. : (Print)
A05       @2 42
A06       @2 11
A08 01  1  ENG  @1 Mapping of antigenic sites on the nucleocapsid protein of the severe acute respiratory syndrome coronavirus
A11 01  1    @1 YUXIAN HE
A11 02  1    @1 YUSEN ZHOU
A11 03  1    @1 HAO WU
A11 04  1    @1 ZHIHUA KOU
A11 05  1    @1 SHUWEN LIU
A11 06  1    @1 SHIBO JIANG
A14 01      @1 Lindsley F. Kimball Research Institute, New York Blood Center @2 New York, New York @3 USA @Z 1 aut. @Z 5 aut. @Z 6 aut.
A14 02      @1 Beijing Institute of Microbiology and Epidemiology, Capital University of Medical Sciences @2 Beijing @3 CHN @Z 2 aut. @Z 4 aut.
A14 03      @1 YouAn Hospital, Capital University of Medical Sciences @2 Beijing @3 CHN @Z 3 aut.
A20       @1 5309-5314
A21       @1 2004
A23 01      @0 ENG
A43 01      @1 INIST @2 17088 @5 354000122608250570
A44       @0 0000 @1 © 2005 INIST-CNRS. All rights reserved.
A45       @0 28 ref.
A47 01  1    @0 05-0019887
A60       @1 P
A61       @0 A
A64 01  1    @0 Journal of clinical microbiology : (Print)
A66 01      @0 USA
C01 01    ENG  @0 Antigenic sites on the nucleocapsid (N) protein of severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) were mapped by Pepscan analysis with overlapping peptides that span the N protein sequence. Two major immunodominant epitopes located in the C-terminal region (amino acids [aal 362 to 412) and middle region (aa 153 to 178) reacted with more than 75% of sera from SARS patients. Several minor immunodominant epitopes were reactive with about 50% of the SARS sera. Antisera from mice immunized with inactivated SARS-CoV recognized the two major immunodominant epitopes and one antigenic site located adjacent to the N-terminal region (aa 76 to 101), which did not react with the sera from SARS patients. Several monoclonal antibodies against SARS-CoV bound to the N- or C-terminal antigenic sites. These results suggest that the above antigenic sites on the N protein are important in eliciting humoral immune response against SARS-CoV in humans and animals and can be used as antigens for developing diagnostic tests.
C02 01  X    @0 002A05C10
C02 02  X    @0 002B05
C03 01  X  FRE  @0 Coronavirus @2 NW @5 01
C03 01  X  ENG  @0 Coronavirus @2 NW @5 01
C03 01  X  SPA  @0 Coronavirus @2 NW @5 01
C03 02  X  FRE  @0 Nucléocapside @5 05
C03 02  X  ENG  @0 Nucleocapsid @5 05
C03 02  X  SPA  @0 Nucleocápside @5 05
C03 03  X  FRE  @0 Protéine @5 06
C03 03  X  ENG  @0 Protein @5 06
C03 03  X  SPA  @0 Proteína @5 06
C03 04  X  FRE  @0 Microbiologie @5 07
C03 04  X  ENG  @0 Microbiology @5 07
C03 04  X  SPA  @0 Microbiología @5 07
C03 05  X  FRE  @0 Syndrome respiratoire aigu sévère @2 NM @5 14
C03 05  X  ENG  @0 Severe acute respiratory syndrome @2 NM @5 14
C03 05  X  SPA  @0 Síndrome respiratorio agudo severo @2 NM @5 14
C07 01  X  FRE  @0 Coronaviridae @2 NW
C07 01  X  ENG  @0 Coronaviridae @2 NW
C07 01  X  SPA  @0 Coronaviridae @2 NW
C07 02  X  FRE  @0 Nidovirales @2 NW
C07 02  X  ENG  @0 Nidovirales @2 NW
C07 02  X  SPA  @0 Nidovirales @2 NW
C07 03  X  FRE  @0 Virus @2 NW
C07 03  X  ENG  @0 Virus @2 NW
C07 03  X  SPA  @0 Virus @2 NW
C07 04  X  FRE  @0 Virose @2 NM
C07 04  X  ENG  @0 Viral disease @2 NM
C07 04  X  SPA  @0 Virosis @2 NM
C07 05  X  FRE  @0 Infection @2 NM
C07 05  X  ENG  @0 Infection @2 NM
C07 05  X  SPA  @0 Infección @2 NM
C07 06  X  FRE  @0 Appareil respiratoire pathologie @5 19
C07 06  X  ENG  @0 Respiratory disease @5 19
C07 06  X  SPA  @0 Aparato respiratorio patología @5 19
C07 07  X  FRE  @0 Poumon pathologie @5 20
C07 07  X  ENG  @0 Lung disease @5 20
C07 07  X  SPA  @0 Pulmón patología @5 20
N21       @1 010
N44 01      @1 OTO
N82       @1 OTO

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:05-0019887

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Mapping of antigenic sites on the nucleocapsid protein of the severe acute respiratory syndrome coronavirus</title>
<author>
<name sortKey="Yuxian He" sort="Yuxian He" uniqKey="Yuxian He" last="Yuxian He">YUXIAN HE</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Lindsley F. Kimball Research Institute, New York Blood Center</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Yusen Zhou" sort="Yusen Zhou" uniqKey="Yusen Zhou" last="Yusen Zhou">YUSEN ZHOU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing Institute of Microbiology and Epidemiology, Capital University of Medical Sciences</s1>
<s2>Beijing</s2>
<s3>CHN</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author>
<name sortKey="Hao Wu" sort="Hao Wu" uniqKey="Hao Wu" last="Hao Wu">HAO WU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>YouAn Hospital, Capital University of Medical Sciences</s1>
<s2>Beijing</s2>
<s3>CHN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author>
<name sortKey="Zhihua Kou" sort="Zhihua Kou" uniqKey="Zhihua Kou" last="Zhihua Kou">ZHIHUA KOU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing Institute of Microbiology and Epidemiology, Capital University of Medical Sciences</s1>
<s2>Beijing</s2>
<s3>CHN</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author>
<name sortKey="Shuwen Liu" sort="Shuwen Liu" uniqKey="Shuwen Liu" last="Shuwen Liu">SHUWEN LIU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Lindsley F. Kimball Research Institute, New York Blood Center</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Shibo Jiang" sort="Shibo Jiang" uniqKey="Shibo Jiang" last="Shibo Jiang">SHIBO JIANG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Lindsley F. Kimball Research Institute, New York Blood Center</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">05-0019887</idno>
<date when="2004">2004</date>
<idno type="stanalyst">PASCAL 05-0019887 INIST</idno>
<idno type="RBID">Pascal:05-0019887</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000755</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000235</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Mapping of antigenic sites on the nucleocapsid protein of the severe acute respiratory syndrome coronavirus</title>
<author>
<name sortKey="Yuxian He" sort="Yuxian He" uniqKey="Yuxian He" last="Yuxian He">YUXIAN HE</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Lindsley F. Kimball Research Institute, New York Blood Center</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Yusen Zhou" sort="Yusen Zhou" uniqKey="Yusen Zhou" last="Yusen Zhou">YUSEN ZHOU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing Institute of Microbiology and Epidemiology, Capital University of Medical Sciences</s1>
<s2>Beijing</s2>
<s3>CHN</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author>
<name sortKey="Hao Wu" sort="Hao Wu" uniqKey="Hao Wu" last="Hao Wu">HAO WU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>YouAn Hospital, Capital University of Medical Sciences</s1>
<s2>Beijing</s2>
<s3>CHN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author>
<name sortKey="Zhihua Kou" sort="Zhihua Kou" uniqKey="Zhihua Kou" last="Zhihua Kou">ZHIHUA KOU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Beijing Institute of Microbiology and Epidemiology, Capital University of Medical Sciences</s1>
<s2>Beijing</s2>
<s3>CHN</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author>
<name sortKey="Shuwen Liu" sort="Shuwen Liu" uniqKey="Shuwen Liu" last="Shuwen Liu">SHUWEN LIU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Lindsley F. Kimball Research Institute, New York Blood Center</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Shibo Jiang" sort="Shibo Jiang" uniqKey="Shibo Jiang" last="Shibo Jiang">SHIBO JIANG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Lindsley F. Kimball Research Institute, New York Blood Center</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Journal of clinical microbiology : (Print)</title>
<title level="j" type="abbreviated">J. clin. microbiol. : (Print)</title>
<idno type="ISSN">0095-1137</idno>
<imprint>
<date when="2004">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Journal of clinical microbiology : (Print)</title>
<title level="j" type="abbreviated">J. clin. microbiol. : (Print)</title>
<idno type="ISSN">0095-1137</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Coronavirus</term>
<term>Microbiology</term>
<term>Nucleocapsid</term>
<term>Protein</term>
<term>Severe acute respiratory syndrome</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Coronavirus</term>
<term>Nucléocapside</term>
<term>Protéine</term>
<term>Microbiologie</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Antigenic sites on the nucleocapsid (N) protein of severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) were mapped by Pepscan analysis with overlapping peptides that span the N protein sequence. Two major immunodominant epitopes located in the C-terminal region (amino acids [aal 362 to 412) and middle region (aa 153 to 178) reacted with more than 75% of sera from SARS patients. Several minor immunodominant epitopes were reactive with about 50% of the SARS sera. Antisera from mice immunized with inactivated SARS-CoV recognized the two major immunodominant epitopes and one antigenic site located adjacent to the N-terminal region (aa 76 to 101), which did not react with the sera from SARS patients. Several monoclonal antibodies against SARS-CoV bound to the N- or C-terminal antigenic sites. These results suggest that the above antigenic sites on the N protein are important in eliciting humoral immune response against SARS-CoV in humans and animals and can be used as antigens for developing diagnostic tests.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0095-1137</s0>
</fA01>
<fA02 i1="01">
<s0>JCMIDW</s0>
</fA02>
<fA03 i2="1">
<s0>J. clin. microbiol. : (Print)</s0>
</fA03>
<fA05>
<s2>42</s2>
</fA05>
<fA06>
<s2>11</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Mapping of antigenic sites on the nucleocapsid protein of the severe acute respiratory syndrome coronavirus</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>YUXIAN HE</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>YUSEN ZHOU</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>HAO WU</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>ZHIHUA KOU</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>SHUWEN LIU</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>SHIBO JIANG</s1>
</fA11>
<fA14 i1="01">
<s1>Lindsley F. Kimball Research Institute, New York Blood Center</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Beijing Institute of Microbiology and Epidemiology, Capital University of Medical Sciences</s1>
<s2>Beijing</s2>
<s3>CHN</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>YouAn Hospital, Capital University of Medical Sciences</s1>
<s2>Beijing</s2>
<s3>CHN</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA20>
<s1>5309-5314</s1>
</fA20>
<fA21>
<s1>2004</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>17088</s2>
<s5>354000122608250570</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2005 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>28 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>05-0019887</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Journal of clinical microbiology : (Print)</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Antigenic sites on the nucleocapsid (N) protein of severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) were mapped by Pepscan analysis with overlapping peptides that span the N protein sequence. Two major immunodominant epitopes located in the C-terminal region (amino acids [aal 362 to 412) and middle region (aa 153 to 178) reacted with more than 75% of sera from SARS patients. Several minor immunodominant epitopes were reactive with about 50% of the SARS sera. Antisera from mice immunized with inactivated SARS-CoV recognized the two major immunodominant epitopes and one antigenic site located adjacent to the N-terminal region (aa 76 to 101), which did not react with the sera from SARS patients. Several monoclonal antibodies against SARS-CoV bound to the N- or C-terminal antigenic sites. These results suggest that the above antigenic sites on the N protein are important in eliciting humoral immune response against SARS-CoV in humans and animals and can be used as antigens for developing diagnostic tests.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002A05C10</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B05</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Coronavirus</s0>
<s2>NW</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Coronavirus</s0>
<s2>NW</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Coronavirus</s0>
<s2>NW</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Nucléocapside</s0>
<s5>05</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Nucleocapsid</s0>
<s5>05</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Nucleocápside</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Protéine</s0>
<s5>06</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Protein</s0>
<s5>06</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Proteína</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Microbiologie</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Microbiology</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Microbiología</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Syndrome respiratoire aigu sévère</s0>
<s2>NM</s2>
<s5>14</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Severe acute respiratory syndrome</s0>
<s2>NM</s2>
<s5>14</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Síndrome respiratorio agudo severo</s0>
<s2>NM</s2>
<s5>14</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Virose</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Viral disease</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Virosis</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Infection</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Infection</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Infección</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Appareil respiratoire pathologie</s0>
<s5>19</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Respiratory disease</s0>
<s5>19</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Aparato respiratorio patología</s0>
<s5>19</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>Poumon pathologie</s0>
<s5>20</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>Lung disease</s0>
<s5>20</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>Pulmón patología</s0>
<s5>20</s5>
</fC07>
<fN21>
<s1>010</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000235 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000235 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:05-0019887
   |texte=   Mapping of antigenic sites on the nucleocapsid protein of the severe acute respiratory syndrome coronavirus
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021